Search

everythinglearnresearchcommunity

for

Search:↓

The health of the sentinel lymph node is the best indicator of survival for patients with thick skin cancer.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

Dermoscopy has improved skin cancer diagnosis and has expanding applications in dermatology, but requires staying updated with new research and techniques.

The immune system plays a key role in tissue repair, affecting both healing quality and regenerative ability.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Hair regrowth in alopecia universalis may be possible by altering immune cells.

Early screening and HPV vaccination reduce cervical cancer risk.

Higher levels of MIG and IP-10 may help diagnose and monitor Alopecia Areata.

Immune cells are essential for skin regeneration using biomaterial scaffolds.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Combining cell conditioning with mild protease digestion effectively shows versican mRNA in mouse skin sections.

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

Hairless mice are more vulnerable to Listeria infection, but gut microbiota can help reduce damage.

Mogamulizumab can cause hair loss and skin rashes.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Immunological treatment improved both neuropathy and alopecia.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

Nanotechnology can improve tissue healing by controlling immune responses.

Skin symptoms in lupus help diagnose and manage the disease early.

The nail immune system is similar to hair but different from skin, with fewer immune markers.

New insights into cell communication in psoriasis suggest innovative drug treatments.